Sign in

CIK 0001835597

  • Emerging growth company

PepGen Inc.

Sign in to watch
Ticker
PEPG
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 703-456-8000
Business address
1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, 02210
  1. 4 Grant or award General Counsel acquired 13,400 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 23,283 shares (grant or award)
  3. 4 Grant or award EVP, Head of R&D acquired 19,430 shares (grant or award)
  4. 4 Grant or award President and CEO acquired 60,719 shares (grant or award)
  5. 4 Open-market sale General Counsel sold 1,432 shares at $1.68 ($2,406)
  6. 4 Open-market sale Chief Financial Officer sold 1,527 shares at $1.68 ($2,565)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Planned sale Chief Medical Officer sold 7,772 shares at an average $18.06 ($140,360)
  10. 4 Planned sale Chief Medical Officer sold 12,625 shares at $18.20 ($229,804)
  11. 4 Planned sale Chief Medical Officer sold 9,189 shares at an average $18.02 ($165,578)
  12. 4 Planned sale Chief Medical Officer sold 912 shares at an average $18.01 ($16,428)
  13. 4 Planned sale Chief Medical Officer sold 9,260 shares at $18.19 ($168,427)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 7 · 122 filings